173 related articles for article (PubMed ID: 27805264)
1. Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Lee HY; Ye YM; Kim SH; Ban GY; Kim SC; Kim JH; Shin YS; Park HS
Allergy; 2017 Apr; 72(4):616-626. PubMed ID: 27805264
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
[TBL] [Abstract][Full Text] [Related]
3. Subphenotypes of nonsteroidal antiinflammatory disease-exacerbated respiratory disease identified by latent class analysis.
Celejewska-Wójcik N; Wójcik K; Ignacak-Popiel M; Ćmiel A; Tyrak K; Gielicz A; Kania A; Nastałek P; Sanak M; Mastalerz L
Allergy; 2020 Apr; 75(4):831-840. PubMed ID: 31803947
[TBL] [Abstract][Full Text] [Related]
4. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
Morales DR; Guthrie B; Lipworth BJ; Jackson C; Donnan PT; Santiago VH
Allergy; 2015 Jul; 70(7):828-35. PubMed ID: 25855099
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
7. Differences in urinary leukotriene E4 levels and distribution of eosinophils between chronic rhinosinusitis patients with aspirin-intolerant and -tolerant asthma.
Yamaguchi T; Ishii T; Yamamoto K; Higashi N; Taniguchi M; Okamoto M
Auris Nasus Larynx; 2016 Jun; 43(3):304-8. PubMed ID: 26527517
[TBL] [Abstract][Full Text] [Related]
8. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
9. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.
Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS
Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637
[TBL] [Abstract][Full Text] [Related]
11. [The value of aspirin challenge tests in the diagnosis of non-steroidal anti-inflammatory drugs-exacerbated respiratory disease].
Xiao H; Zhang L; Lin H; Xiao YL; Zhang HT; Jia QR; Xu F; Meng J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Aug; 58(8):741-746. PubMed ID: 37550033
[No Abstract] [Full Text] [Related]
12. Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease.
Cahill KN; Laidlaw TM
Immunol Allergy Clin North Am; 2016 Nov; 36(4):681-691. PubMed ID: 27712763
[TBL] [Abstract][Full Text] [Related]
13. Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
Tyrak KE; Kupryś-Lipińska I; Czarnobilska E; Jakieła B; Pajdzik K; Ćmiel A; Plutecka H; Koziej M; Gawrońska A; Konduracka E; Kuna P; Sanak M; Mastalerz L
Respir Med; 2019 Jun; 152():51-59. PubMed ID: 31128610
[TBL] [Abstract][Full Text] [Related]
14. Potential Biomarkers for NSAID-Exacerbated Respiratory Disease.
Park H; Choi Y; Jung CG; Park HS
Mediators Inflamm; 2017; 2017():8160148. PubMed ID: 28852271
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.
Stevenson DD; White AA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):643-655. PubMed ID: 27712760
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity to dipyrone in aspirin-exacerbated respiratory disease patients is associated with urticaria.
Agondi RC; Dias GMFS; Assis JP; Pacheco R; Kalil J; Giavina-Bianchi P
Respir Med; 2020; 170():106041. PubMed ID: 32843172
[TBL] [Abstract][Full Text] [Related]
17. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs.
Doña I; Barrionuevo E; Salas M; Laguna JJ; Agúndez J; García-Martín E; Bogas G; Perkins JR; Cornejo-García JA; Torres MJ
Sci Rep; 2018 Nov; 8(1):16710. PubMed ID: 30420763
[TBL] [Abstract][Full Text] [Related]
18. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
19. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs.
Zembowicz A; Mastalerz L; Setkowicz M; Radziszewski W; Szczeklik A
Arch Dermatol; 2003 Dec; 139(12):1577-82. PubMed ID: 14676074
[TBL] [Abstract][Full Text] [Related]
20. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]